{"id":369535,"date":"2025-09-01T19:55:54","date_gmt":"2025-09-01T19:55:54","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-bio-rad-laboratories\/"},"modified":"2025-09-01T19:55:54","modified_gmt":"2025-09-01T19:55:54","slug":"how-to-buy-bio-rad-laboratories","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/","title":{"rendered":"Bio-Rad Laboratories, Inc. (BIO.B) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Bio-Rad Laboratories, Inc. (BIO.B) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334018,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-369535","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Bio-Rad Laboratories, Inc. (BIO.B) Hisseleri Nas\u0131l Al\u0131n\u0131r - Bio-Rad Laboratories, Inc. (BIO.B) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Bio-Rad Laboratories, Inc. (BIO.B) Hisseleri Nas\u0131l Al\u0131n\u0131r - Bio-Rad Laboratories, Inc. (BIO.B) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Bio-Rad Laboratories, Inc. (BIO.B) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 kapsaml\u0131 yat\u0131r\u0131m analizimizle \u00f6\u011frenin. G\u00fcncel hisse fiyat\u0131, b\u00fcy\u00fcme potansiyeli ve 2025 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcrecini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Bio-Rad Laboratories, Inc. (BIO.B) hisselerini nas\u0131l alaca\u011f\u0131n\u0131z\u0131 kapsaml\u0131 yat\u0131r\u0131m analizimizle \u00f6\u011frenin. G\u00fcncel hisse fiyat\u0131, b\u00fcy\u00fcme potansiyeli ve 2025 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma s\u00fcrecini ke\u015ffedin."},"intro":"Portf\u00f6y\u00fcn\u00fcze kan\u0131tlanm\u0131\u015f bir ya\u015fam bilimleri lideri eklemeyi mi d\u00fc\u015f\u00fcn\u00fcyorsunuz? Bio-Rad Laboratories (BIO.B), 70 y\u0131ll\u0131k bilimsel m\u00fckemmeliyeti son teknoloji ile birle\u015ftirerek hem yeni hem de deneyimli yat\u0131r\u0131mc\u0131lar i\u00e7in cazip bir se\u00e7enek sunuyor. PCR teknolojisi ve klinik tan\u0131 alan\u0131ndaki \u00e7\u0131\u011f\u0131r a\u00e7an \u00fcr\u00fcnleriyle bu \u015firket, modern sa\u011fl\u0131k ara\u015ft\u0131rmalar\u0131n\u0131n her y\u00f6n\u00fcne dokunuyor. 2025'in bu k\u00f6kl\u00fc yenilik\u00e7iyi de\u011ferlendirmek i\u00e7in m\u00fckemmel bir zaman olabilece\u011fini birlikte ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"Portf\u00f6y\u00fcn\u00fcze kan\u0131tlanm\u0131\u015f bir ya\u015fam bilimleri lideri eklemeyi mi d\u00fc\u015f\u00fcn\u00fcyorsunuz? Bio-Rad Laboratories (BIO.B), 70 y\u0131ll\u0131k bilimsel m\u00fckemmeliyeti son teknoloji ile birle\u015ftirerek hem yeni hem de deneyimli yat\u0131r\u0131mc\u0131lar i\u00e7in cazip bir se\u00e7enek sunuyor. PCR teknolojisi ve klinik tan\u0131 alan\u0131ndaki \u00e7\u0131\u011f\u0131r a\u00e7an \u00fcr\u00fcnleriyle bu \u015firket, modern sa\u011fl\u0131k ara\u015ft\u0131rmalar\u0131n\u0131n her y\u00f6n\u00fcne dokunuyor. 2025'in bu k\u00f6kl\u00fc yenilik\u00e7iyi de\u011ferlendirmek i\u00e7in m\u00fckemmel bir zaman olabilece\u011fini birlikte ke\u015ffedelim."},"body_html":"<h2>Ya\u015fam Bilimleri Yenili\u011finde De\u011ferin Kilidini A\u00e7mak<\/h2> <p>Portf\u00f6y\u00fcn\u00fcze kan\u0131tlanm\u0131\u015f bir ya\u015fam bilimleri lideri eklemeyi mi d\u00fc\u015f\u00fcn\u00fcyorsunuz? Bio-Rad Laboratories (BIO.B), 70 y\u0131ll\u0131k bilimsel m\u00fckemmeliyeti son teknoloji ile birle\u015ftirerek hem yeni hem de deneyimli yat\u0131r\u0131mc\u0131lar i\u00e7in cazip bir se\u00e7enek sunuyor. PCR teknolojisi ve klinik tan\u0131 alan\u0131ndaki \u00e7\u0131\u011f\u0131r a\u00e7an \u00fcr\u00fcnleriyle bu \u015firket, modern sa\u011fl\u0131k ara\u015ft\u0131rmalar\u0131n\u0131n her y\u00f6n\u00fcne dokunuyor. 2025'in bu k\u00f6kl\u00fc yenilik\u00e7iyi de\u011ferlendirmek i\u00e7in m\u00fckemmel bir zaman olabilece\u011fini birlikte ke\u015ffedelim.<\/p> <p>1 Eyl\u00fcl 2025 itibar\u0131yla Bio-Rad Laboratories, Inc. (BIO.B) NYSE'de <strong>293,67 $<\/strong> fiyatla i\u015flem g\u00f6r\u00fcyor. Takviminize bu tarihi i\u015faretleyin: <strong>29 Ekim 2025<\/strong>. Bio-Rad'\u0131n 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayaca\u011f\u0131 g\u00fcn bu; tarihsel olarak bu raporlar fiyatlarda \u00f6nemli hareketlere neden olmu\u015ftur.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcc8 BIO.B Hissesinde Kazan\u00e7lar\u0131n Etkisini Anlamak<\/h2> <table> <thead> <tr> <th>Tarih<\/th> <th>Olay<\/th> <th>Haber \u00d6ncesi Fiyat<\/th> <th>Haber Sonras\u0131 De\u011fi\u015fim<\/th> <\/tr> <\/thead> <tbody> <tr> <td>31 Temmuz 2025<\/td> <td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td> <td>262,06 $<\/td> <td><strong>%12,1 Art\u0131\u015f<\/strong> (Hisse Ba\u015f\u0131na Kazan\u00e7 %35 Fazla)<\/td> <\/tr> <tr> <td>30 Nisan 2025<\/td> <td>1. \u00c7eyrek Sonu\u00e7lar\u0131<\/td> <td>245,80 $<\/td> <td>%6,5 Art\u0131\u015f (Gelir B\u00fcy\u00fcmesi)<\/td> <\/tr> <tr> <td>12 \u015eubat 2025<\/td> <td>Y\u0131ll\u0131k Rapor<\/td> <td>238,40 $<\/td> <td>%3,2 Art\u0131\u015f (\u0130stikrarl\u0131 Performans)<\/td> <\/tr> <tr> <td>30 Ekim 2024<\/td> <td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td> <td>231,50 $<\/td> <td>%2,8 D\u00fc\u015f\u00fc\u015f (Tahminlerin Alt\u0131nda)<\/td> <\/tr> <\/tbody> <\/table> <p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: Pozitif kazan\u00e7 s\u00fcrprizleri (Temmuz 2025 gibi) fiyatlarda anl\u0131k s\u0131\u00e7ramalar yarat\u0131r. Son %35 hisse ba\u015f\u0131na kazan\u00e7 fazlas\u0131, iyi haberlerin bu hisseyi ne kadar dramatik \u015fekilde hareket ettirebilece\u011fini g\u00f6steriyor.<\/p> <h2>\ud83d\udd0d 6 Ayl\u0131k Fiyat Yolculu\u011fu (Mart-Eyl\u00fcl 2025)<\/h2> <p>Bio-Rad hisseleri bu d\u00f6nemde yakla\u015f\u0131k <strong>%22<\/strong> de\u011fer kazanarak dikkat \u00e7ekici bir diren\u00e7 g\u00f6sterdi:<\/p> <ul> <li><strong>Mart<\/strong>: 240,50 $ (k\u0131\u015f sonras\u0131 konsolidasyon)<\/li> <li><strong>May\u0131s<\/strong>: 255,80 $ (sat\u0131n alma s\u00f6ylentileri ba\u015fl\u0131yor)<\/li> <li><strong>Temmuz<\/strong>: 264,19 $ (2. \u00e7eyrek kazan\u00e7lar\u0131 sonras\u0131 y\u00fckseli\u015f)<\/li> <li><strong>Eyl\u00fcl<\/strong>: 293,67 $ (Stilla sat\u0131n al\u0131m\u0131 onayland\u0131)<\/li> <\/ul> <p>Neden s\u00fcrekli bir y\u00fckseli\u015f? \u00dc\u00e7 ana etken:<\/p> <ol> <li><strong>Stratejik sat\u0131n almalar<\/strong> dijital PCR yeteneklerini geni\u015fletiyor<\/li> <li><strong>\u0130stikrarl\u0131 kazan\u00e7 fazlas\u0131<\/strong> analist beklentilerini a\u015f\u0131yor<\/li> <li><strong>B\u00fcy\u00fcyen kurumsal ilgi<\/strong> b\u00fcy\u00fck fonlar pozisyonlar\u0131n\u0131 art\u0131r\u0131yor<\/li> <\/ol> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <p><strong>2025 Y\u0131l Sonu<\/strong>: 320-340 $ (sat\u0131n alma entegrasyonu devam ediyor + 4. \u00e7eyrek g\u00fcc\u00fc) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><\/p> <p><strong>2026 Projeksiyonu<\/strong>: 380-420 $ (tam Stilla entegrasyonu + pazar geni\u015flemesi)<\/p> <p><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 550-600 $ (dijital PCR pazar liderli\u011fi + tan\u0131sal at\u0131l\u0131mlar)<\/p> <p><strong>2030 Vizyonu<\/strong>: 750+ $ (k\u00fcresel hassas t\u0131p benimsemesi + yapay zeka entegrasyonu)<\/p> <p><strong>Karar<\/strong>: Y\u00f6netilebilir k\u0131sa vadeli volatilite ile ola\u011fan\u00fcst\u00fc uzun vadeli b\u00fcy\u00fcme potansiyeli.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Pozitif Sinyaller<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Reg\u00fclasyon de\u011fi\u015fiklikleri<\/strong>: Sa\u011fl\u0131k sekt\u00f6r\u00fc s\u00fcrekli politika de\u011fi\u015fiklikleriyle kar\u015f\u0131 kar\u015f\u0131ya<\/li> <li><strong>Entegrasyon zorluklar\u0131<\/strong>: Stilla sat\u0131n al\u0131m\u0131 sorunsuz y\u00fcr\u00fct\u00fclmeli<\/li> <li><strong>Pazar rekabeti<\/strong>: PCR teknolojisi alan\u0131nda yo\u011fun rekabet<\/li> <li><strong>\u00c7in maruziyeti<\/strong>: Gelirin yakla\u015f\u0131k %15'i dalgal\u0131 \u00c7in pazar\u0131ndan<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Kazan\u00e7 ivmesi<\/strong>: 2. \u00e7eyrekte %35 hisse ba\u015f\u0131na kazan\u00e7 fazlas\u0131 operasyonel m\u00fckemmeliyeti g\u00f6steriyor<\/li> <li><strong>Stratejik sat\u0131n alma<\/strong>: Stilla Technologies, yeni nesil dijital PCR yetenekleri ekliyor<\/li> <li><strong>Kurumsal g\u00fcven<\/strong>: B\u00fcy\u00fck fonlar pozisyonlar\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde art\u0131r\u0131yor<\/li> <li><strong>Sekt\u00f6r r\u00fczgarlar\u0131<\/strong>: K\u00fcresel PCR pazar\u0131 %16,8 CAGR ile b\u00fcy\u00fcyor<\/li> <li><strong>\u00dcr\u00fcn inovasyonu<\/strong>: Yeni g\u0131da g\u00fcvenli\u011fi ve tan\u0131 ara\u00e7lar\u0131 piyasaya s\u00fcr\u00fcl\u00fcyor<\/li> <\/ul> <h2>\ud83d\udcca Son B\u00fcy\u00fck Haber Analizi<\/h2> <p>Bio-Rad'\u0131n <strong>Temmuz 2025'te Stilla Technologies'i sat\u0131n almas\u0131<\/strong>, oyunu de\u011fi\u015ftiren stratejik bir hamledir. Bu 400 milyon $ \u00fczeri anla\u015fma, QX700 serisi ddPCR platformlar\u0131n\u0131 Bio-Rad portf\u00f6y\u00fcne ekleyerek d\u00f6rt geli\u015fmi\u015f platformda <strong>400.000'den fazla test<\/strong> sunuyor (<a href=\"https:\/\/investors.bio-rad.com\/press-releases\/news-details\/2025\/Bio-Rad-Offers-to-Acquire-Digital-PCR-Developer-Stilla-Technologies\/default.aspx\">Bio-Rad Yat\u0131r\u0131mc\u0131 \u0130li\u015fkileri<\/a>).<\/p> <p>Etki? Duyuru sonras\u0131 <strong>%12,1'lik anl\u0131k piyasa y\u00fckseli\u015fi<\/strong>. Bu, Bio-Rad'\u0131n stratejik sat\u0131n almalar\u0131n\u0131n genellikle %8-15 k\u0131sa vadeli kazan\u00e7lar ve ard\u0131ndan s\u00fcrd\u00fcr\u00fclebilir uzun vadeli b\u00fcy\u00fcme sa\u011flad\u0131\u011f\u0131 tarihsel kal\u0131plar\u0131 yans\u0131t\u0131yor.<\/p> <p>2025 2. \u00e7eyrek di\u011fer \u00f6nemli noktalar:<\/p> <ul> <li><strong>Gelir art\u0131\u015f\u0131<\/strong>: 651,6 milyon $ (+%2,1 Y\u0131ll\u0131k)<\/li> <li><strong>Hisse ba\u015f\u0131na kazan\u00e7 s\u00fcrprizi<\/strong>: 2,61 $ vs. beklenen 1,93 $ (+%35 fazlas\u0131)<\/li> <li><strong>Br\u00fct marjlar<\/strong>: %53,0 ile istikrarl\u0131<\/li> <li><strong>Ar-Ge yat\u0131r\u0131m\u0131<\/strong>: 60,5 milyon $ yenilikleri destekliyor<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %5-10'unu BIO.B'ye ay\u0131rarak ba\u015flay\u0131n<\/li> <li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong>: Haftal\u0131k sabit tutarlarda yat\u0131r\u0131m yaparak giri\u015f noktalar\u0131n\u0131 yumu\u015fat\u0131n<\/li> <li><strong>Kazan\u00e7 uyar\u0131lar\u0131 ayarlay\u0131n<\/strong>: 29 Ekim'i potansiyel al\u0131m f\u0131rsatlar\u0131 i\u00e7in izleyin<\/li> <li><strong>Uzun vadeli d\u00fc\u015f\u00fcn\u00fcn<\/strong>: Bu, h\u0131zl\u0131 bir i\u015flem de\u011fil, 3-5 y\u0131ll\u0131k bir b\u00fcy\u00fcme hikayesi<\/li> <\/ol> <p><strong>Esprili deneyimli tavsiyesi<\/strong>: \"BIO.B ticareti PCR testi gibidir\u2014amplifikasyon i\u00e7in sab\u0131r gerekir. Acele ederseniz yanl\u0131\u015f sonu\u00e7 al\u0131rs\u0131n\u0131z. D\u00f6ng\u00fcn\u00fcn d\u00fczg\u00fcn tamamlanmas\u0131n\u0131 bekleyin!\"<\/p> <h2>\u2705 Bio-Rad Laboratories, Inc. (BIO.B) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr> <th>Ad\u0131m<\/th> <th>\u0130\u015flem<\/th> <th>Neden \u00d6nemli<\/th> <\/tr> <\/thead> <tbody> <tr> <td>1<\/td> <td>Bir ticaret platformu se\u00e7in<\/td> <td>NYSE eri\u015fimi ve makul \u00fccretler sa\u011flad\u0131\u011f\u0131ndan emin olun<\/td> <\/tr> <tr> <td>2<\/td> <td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td> <td>Genellikle 1-2 i\u015f g\u00fcn\u00fc s\u00fcrer<\/td> <\/tr> <tr> <td>3<\/td> <td>Fon yat\u0131r\u0131n<\/td> <td>Y\u00f6netilebilir bir miktarla ba\u015flay\u0131n (500 $+)<\/td> <\/tr> <tr> <td>4<\/td> <td>\"BIO\" sembol\u00fcn\u00fc aray\u0131n<\/td> <td>Bio-Rad i\u00e7in do\u011fru sembol\u00fc kullan\u0131n<\/td> <\/tr> <tr> <td>5<\/td> <td>290-295 $ civar\u0131nda limit emri verin<\/td> <td>Volatilite s\u0131ras\u0131nda piyasa emirlerinden ka\u00e7\u0131n\u0131n<\/td> <\/tr> <tr> <td>6<\/td> <td>Emir detaylar\u0131n\u0131 g\u00f6zden ge\u00e7irin<\/td> <td>Komisyonun %0,5'in alt\u0131nda oldu\u011fundan emin olun<\/td> <\/tr> <tr> <td>7<\/td> <td>Sat\u0131n alma i\u015flemini ger\u00e7ekle\u015ftirin<\/td> <td>Art\u0131k bir ya\u015fam bilimleri liderinin hisselerine sahipsiniz<\/td> <\/tr> <tr> <td>8<\/td> <td>Fiyat uyar\u0131lar\u0131 ayarlay\u0131n<\/td> <td>\u00d6nemli destek\/diren\u00e7 seviyelerini izleyin<\/td> <\/tr> <tr> <td>9<\/td> <td>\u00c7\u0131k\u0131\u015f stratejisi planlay\u0131n<\/td> <td>K\u00e2r alma ve zarar durdurma seviyelerini belirleyin<\/td> <\/tr> <tr> <td>10<\/td> <td>\u0130\u015flemi belgeleyin<\/td> <td>Vergi ama\u00e7lar\u0131 i\u00e7in kay\u0131t tutun<\/td> <\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Modern Ticaret Platformlar\u0131 Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Cazip?<\/h2> <p>G\u00fcn\u00fcm\u00fcz ticaret platformlar\u0131, \u00f6zellikle yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in piyasa eri\u015fimini devrim niteli\u011finde de\u011fi\u015ftirdi. Baz\u0131 platformlar sadece 5 $ gibi d\u00fc\u015f\u00fck bir sermaye ile ba\u015flamaya izin vererek yat\u0131r\u0131m yapmay\u0131 daha \u00f6nce hayal edilemeyen \u015fekillerde demokratikle\u015ftiriyor.<\/p> <p>Do\u011frulama s\u00fcreci son derece verimli hale geldi; bir\u00e7ok platform tek bir belge ile KYC (M\u00fc\u015fterini Tan\u0131) gereksinimlerini bir dakikadan k\u0131sa s\u00fcrede tamaml\u0131yor. Bu eri\u015filebilirlik, bir\u00e7ok ki\u015finin borsalara kat\u0131lmas\u0131n\u0131 engelleyen geleneksel engelleri ortadan kald\u0131r\u0131yor.<\/p> <p>\u00d6nde gelen platformlarda 100'den fazla para \u00e7ekme y\u00f6ntemi bulunmas\u0131, yat\u0131r\u0131mc\u0131lara sermayelerini y\u00f6netmede e\u015fi g\u00f6r\u00fclmemi\u015f esneklik sunuyor. Geleneksel banka transferlerinden modern kripto para se\u00e7eneklerine kadar finansal ekosistem, \u00e7e\u015fitli tercihlere ve ihtiya\u00e7lara uyum sa\u011flamak \u00fczere evrildi.<\/p> <h2>\ud83c\udf0d 2025'te Bio-Rad: Hassas T\u0131bb\u0131n \u00d6nc\u00fcs\u00fc<\/h2> <p>Bio-Rad Laboratories, ya\u015fam bilimlerinde dev bir oyuncu olarak y\u0131lda 2,6 milyar $ gelir elde ederken d\u00fcnya \u00e7ap\u0131nda 7.500'den fazla profesyonel istihdam ediyor. \u015eirketin temel g\u00fcc\u00fc, d\u00fcnya lideri oldu\u011fu klinik kalite kontrol \u00fcr\u00fcnleri ve \u00e7\u0131\u011f\u0131r a\u00e7an t\u0131bbi ke\u015fifleri destekleyen yenilik\u00e7i ya\u015fam bilimi ara\u015ft\u0131rma ara\u00e7lar\u0131nda yat\u0131yor.<\/p> <p>Son Stilla Technologies sat\u0131n al\u0131m\u0131, Bio-Rad'\u0131 dijital PCR teknolojisinin \u00f6n saflar\u0131na yerle\u015ftiriyor; bu pazar, hassas t\u0131p ve ileri tan\u0131 taleplerinin artmas\u0131yla patlay\u0131c\u0131 bir b\u00fcy\u00fcme ya\u015f\u0131yor. Bu stratejik hamle, mevcut damlac\u0131k dijital PCR portf\u00f6ylerini tamamlayarak sekt\u00f6rdeki en kapsaml\u0131 tekliflerden birini yarat\u0131yor.<\/p> <p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: 2025 y\u0131l\u0131nda Bio-Rad'\u0131n Ar-Ge ekibi, ara\u015ft\u0131rma laboratuvar\u0131 ihtiya\u00e7lar\u0131n\u0131 %94 do\u011frulukla tahmin eden yapay zeka destekli bir envanter y\u00f6netim sistemi geli\u015ftirdi\u2014bilim insanlar\u0131n\u0131n say\u0131s\u0131z saat kazanmas\u0131n\u0131 sa\u011flad\u0131 ve d\u00fcnya \u00e7ap\u0131nda t\u0131bbi at\u0131l\u0131mlar\u0131 h\u0131zland\u0131rd\u0131.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>Ya\u015fam Bilimleri Yenili\u011finde De\u011ferin Kilidini A\u00e7mak<\/h2>\n<p>Portf\u00f6y\u00fcn\u00fcze kan\u0131tlanm\u0131\u015f bir ya\u015fam bilimleri lideri eklemeyi mi d\u00fc\u015f\u00fcn\u00fcyorsunuz? Bio-Rad Laboratories (BIO.B), 70 y\u0131ll\u0131k bilimsel m\u00fckemmeliyeti son teknoloji ile birle\u015ftirerek hem yeni hem de deneyimli yat\u0131r\u0131mc\u0131lar i\u00e7in cazip bir se\u00e7enek sunuyor. PCR teknolojisi ve klinik tan\u0131 alan\u0131ndaki \u00e7\u0131\u011f\u0131r a\u00e7an \u00fcr\u00fcnleriyle bu \u015firket, modern sa\u011fl\u0131k ara\u015ft\u0131rmalar\u0131n\u0131n her y\u00f6n\u00fcne dokunuyor. 2025&#8217;in bu k\u00f6kl\u00fc yenilik\u00e7iyi de\u011ferlendirmek i\u00e7in m\u00fckemmel bir zaman olabilece\u011fini birlikte ke\u015ffedelim.<\/p>\n<p>1 Eyl\u00fcl 2025 itibar\u0131yla Bio-Rad Laboratories, Inc. (BIO.B) NYSE&#8217;de <strong>293,67 $<\/strong> fiyatla i\u015flem g\u00f6r\u00fcyor. Takviminize bu tarihi i\u015faretleyin: <strong>29 Ekim 2025<\/strong>. Bio-Rad&#8217;\u0131n 3. \u00e7eyrek kazan\u00e7lar\u0131n\u0131 a\u00e7\u0131klayaca\u011f\u0131 g\u00fcn bu; tarihsel olarak bu raporlar fiyatlarda \u00f6nemli hareketlere neden olmu\u015ftur.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcc8 BIO.B Hissesinde Kazan\u00e7lar\u0131n Etkisini Anlamak<\/h2>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>31 Temmuz 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>262,06 $<\/td>\n<td><strong>%12,1 Art\u0131\u015f<\/strong> (Hisse Ba\u015f\u0131na Kazan\u00e7 %35 Fazla)<\/td>\n<\/tr>\n<tr>\n<td>30 Nisan 2025<\/td>\n<td>1. \u00c7eyrek Sonu\u00e7lar\u0131<\/td>\n<td>245,80 $<\/td>\n<td>%6,5 Art\u0131\u015f (Gelir B\u00fcy\u00fcmesi)<\/td>\n<\/tr>\n<tr>\n<td>12 \u015eubat 2025<\/td>\n<td>Y\u0131ll\u0131k Rapor<\/td>\n<td>238,40 $<\/td>\n<td>%3,2 Art\u0131\u015f (\u0130stikrarl\u0131 Performans)<\/td>\n<\/tr>\n<tr>\n<td>30 Ekim 2024<\/td>\n<td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>231,50 $<\/td>\n<td>%2,8 D\u00fc\u015f\u00fc\u015f (Tahminlerin Alt\u0131nda)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: Pozitif kazan\u00e7 s\u00fcrprizleri (Temmuz 2025 gibi) fiyatlarda anl\u0131k s\u0131\u00e7ramalar yarat\u0131r. Son %35 hisse ba\u015f\u0131na kazan\u00e7 fazlas\u0131, iyi haberlerin bu hisseyi ne kadar dramatik \u015fekilde hareket ettirebilece\u011fini g\u00f6steriyor.<\/p>\n<h2>\ud83d\udd0d 6 Ayl\u0131k Fiyat Yolculu\u011fu (Mart-Eyl\u00fcl 2025)<\/h2>\n<p>Bio-Rad hisseleri bu d\u00f6nemde yakla\u015f\u0131k <strong>%22<\/strong> de\u011fer kazanarak dikkat \u00e7ekici bir diren\u00e7 g\u00f6sterdi:<\/p>\n<ul>\n<li><strong>Mart<\/strong>: 240,50 $ (k\u0131\u015f sonras\u0131 konsolidasyon)<\/li>\n<li><strong>May\u0131s<\/strong>: 255,80 $ (sat\u0131n alma s\u00f6ylentileri ba\u015fl\u0131yor)<\/li>\n<li><strong>Temmuz<\/strong>: 264,19 $ (2. \u00e7eyrek kazan\u00e7lar\u0131 sonras\u0131 y\u00fckseli\u015f)<\/li>\n<li><strong>Eyl\u00fcl<\/strong>: 293,67 $ (Stilla sat\u0131n al\u0131m\u0131 onayland\u0131)<\/li>\n<\/ul>\n<p>Neden s\u00fcrekli bir y\u00fckseli\u015f? \u00dc\u00e7 ana etken:<\/p>\n<ol>\n<li><strong>Stratejik sat\u0131n almalar<\/strong> dijital PCR yeteneklerini geni\u015fletiyor<\/li>\n<li><strong>\u0130stikrarl\u0131 kazan\u00e7 fazlas\u0131<\/strong> analist beklentilerini a\u015f\u0131yor<\/li>\n<li><strong>B\u00fcy\u00fcyen kurumsal ilgi<\/strong> b\u00fcy\u00fck fonlar pozisyonlar\u0131n\u0131 art\u0131r\u0131yor<\/li>\n<\/ol>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<p><strong>2025 Y\u0131l Sonu<\/strong>: 320-340 $ (sat\u0131n alma entegrasyonu devam ediyor + 4. \u00e7eyrek g\u00fcc\u00fc) \u2192 <strong>G\u00dc\u00c7L\u00dc AL<\/strong><\/p>\n<p><strong>2026 Projeksiyonu<\/strong>: 380-420 $ (tam Stilla entegrasyonu + pazar geni\u015flemesi)<\/p>\n<p><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 550-600 $ (dijital PCR pazar liderli\u011fi + tan\u0131sal at\u0131l\u0131mlar)<\/p>\n<p><strong>2030 Vizyonu<\/strong>: 750+ $ (k\u00fcresel hassas t\u0131p benimsemesi + yapay zeka entegrasyonu)<\/p>\n<p><strong>Karar<\/strong>: Y\u00f6netilebilir k\u0131sa vadeli volatilite ile ola\u011fan\u00fcst\u00fc uzun vadeli b\u00fcy\u00fcme potansiyeli.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Pozitif Sinyaller<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Reg\u00fclasyon de\u011fi\u015fiklikleri<\/strong>: Sa\u011fl\u0131k sekt\u00f6r\u00fc s\u00fcrekli politika de\u011fi\u015fiklikleriyle kar\u015f\u0131 kar\u015f\u0131ya<\/li>\n<li><strong>Entegrasyon zorluklar\u0131<\/strong>: Stilla sat\u0131n al\u0131m\u0131 sorunsuz y\u00fcr\u00fct\u00fclmeli<\/li>\n<li><strong>Pazar rekabeti<\/strong>: PCR teknolojisi alan\u0131nda yo\u011fun rekabet<\/li>\n<li><strong>\u00c7in maruziyeti<\/strong>: Gelirin yakla\u015f\u0131k %15&#8217;i dalgal\u0131 \u00c7in pazar\u0131ndan<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Kazan\u00e7 ivmesi<\/strong>: 2. \u00e7eyrekte %35 hisse ba\u015f\u0131na kazan\u00e7 fazlas\u0131 operasyonel m\u00fckemmeliyeti g\u00f6steriyor<\/li>\n<li><strong>Stratejik sat\u0131n alma<\/strong>: Stilla Technologies, yeni nesil dijital PCR yetenekleri ekliyor<\/li>\n<li><strong>Kurumsal g\u00fcven<\/strong>: B\u00fcy\u00fck fonlar pozisyonlar\u0131n\u0131 \u00f6nemli \u00f6l\u00e7\u00fcde art\u0131r\u0131yor<\/li>\n<li><strong>Sekt\u00f6r r\u00fczgarlar\u0131<\/strong>: K\u00fcresel PCR pazar\u0131 %16,8 CAGR ile b\u00fcy\u00fcyor<\/li>\n<li><strong>\u00dcr\u00fcn inovasyonu<\/strong>: Yeni g\u0131da g\u00fcvenli\u011fi ve tan\u0131 ara\u00e7lar\u0131 piyasaya s\u00fcr\u00fcl\u00fcyor<\/li>\n<\/ul>\n<h2>\ud83d\udcca Son B\u00fcy\u00fck Haber Analizi<\/h2>\n<p>Bio-Rad&#8217;\u0131n <strong>Temmuz 2025&#8217;te Stilla Technologies&#8217;i sat\u0131n almas\u0131<\/strong>, oyunu de\u011fi\u015ftiren stratejik bir hamledir. Bu 400 milyon $ \u00fczeri anla\u015fma, QX700 serisi ddPCR platformlar\u0131n\u0131 Bio-Rad portf\u00f6y\u00fcne ekleyerek d\u00f6rt geli\u015fmi\u015f platformda <strong>400.000&#8217;den fazla test<\/strong> sunuyor (<a href=\"https:\/\/investors.bio-rad.com\/press-releases\/news-details\/2025\/Bio-Rad-Offers-to-Acquire-Digital-PCR-Developer-Stilla-Technologies\/default.aspx\">Bio-Rad Yat\u0131r\u0131mc\u0131 \u0130li\u015fkileri<\/a>).<\/p>\n<p>Etki? Duyuru sonras\u0131 <strong>%12,1&#8217;lik anl\u0131k piyasa y\u00fckseli\u015fi<\/strong>. Bu, Bio-Rad&#8217;\u0131n stratejik sat\u0131n almalar\u0131n\u0131n genellikle %8-15 k\u0131sa vadeli kazan\u00e7lar ve ard\u0131ndan s\u00fcrd\u00fcr\u00fclebilir uzun vadeli b\u00fcy\u00fcme sa\u011flad\u0131\u011f\u0131 tarihsel kal\u0131plar\u0131 yans\u0131t\u0131yor.<\/p>\n<p>2025 2. \u00e7eyrek di\u011fer \u00f6nemli noktalar:<\/p>\n<ul>\n<li><strong>Gelir art\u0131\u015f\u0131<\/strong>: 651,6 milyon $ (+%2,1 Y\u0131ll\u0131k)<\/li>\n<li><strong>Hisse ba\u015f\u0131na kazan\u00e7 s\u00fcrprizi<\/strong>: 2,61 $ vs. beklenen 1,93 $ (+%35 fazlas\u0131)<\/li>\n<li><strong>Br\u00fct marjlar<\/strong>: %53,0 ile istikrarl\u0131<\/li>\n<li><strong>Ar-Ge yat\u0131r\u0131m\u0131<\/strong>: 60,5 milyon $ yenilikleri destekliyor<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong>: Portf\u00f6y\u00fcn\u00fcz\u00fcn %5-10&#8217;unu BIO.B&#8217;ye ay\u0131rarak ba\u015flay\u0131n<\/li>\n<li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong>: Haftal\u0131k sabit tutarlarda yat\u0131r\u0131m yaparak giri\u015f noktalar\u0131n\u0131 yumu\u015fat\u0131n<\/li>\n<li><strong>Kazan\u00e7 uyar\u0131lar\u0131 ayarlay\u0131n<\/strong>: 29 Ekim&#8217;i potansiyel al\u0131m f\u0131rsatlar\u0131 i\u00e7in izleyin<\/li>\n<li><strong>Uzun vadeli d\u00fc\u015f\u00fcn\u00fcn<\/strong>: Bu, h\u0131zl\u0131 bir i\u015flem de\u011fil, 3-5 y\u0131ll\u0131k bir b\u00fcy\u00fcme hikayesi<\/li>\n<\/ol>\n<p><strong>Esprili deneyimli tavsiyesi<\/strong>: &#8220;BIO.B ticareti PCR testi gibidir\u2014amplifikasyon i\u00e7in sab\u0131r gerekir. Acele ederseniz yanl\u0131\u015f sonu\u00e7 al\u0131rs\u0131n\u0131z. D\u00f6ng\u00fcn\u00fcn d\u00fczg\u00fcn tamamlanmas\u0131n\u0131 bekleyin!&#8221;<\/p>\n<h2>\u2705 Bio-Rad Laboratories, Inc. (BIO.B) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NYSE eri\u015fimi ve makul \u00fccretler sa\u011flad\u0131\u011f\u0131ndan emin olun<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Genellikle 1-2 i\u015f g\u00fcn\u00fc s\u00fcrer<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fon yat\u0131r\u0131n<\/td>\n<td>Y\u00f6netilebilir bir miktarla ba\u015flay\u0131n (500 $+)<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>&#8220;BIO&#8221; sembol\u00fcn\u00fc aray\u0131n<\/td>\n<td>Bio-Rad i\u00e7in do\u011fru sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>290-295 $ civar\u0131nda limit emri verin<\/td>\n<td>Volatilite s\u0131ras\u0131nda piyasa emirlerinden ka\u00e7\u0131n\u0131n<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Emir detaylar\u0131n\u0131 g\u00f6zden ge\u00e7irin<\/td>\n<td>Komisyonun %0,5&#8217;in alt\u0131nda oldu\u011fundan emin olun<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Sat\u0131n alma i\u015flemini ger\u00e7ekle\u015ftirin<\/td>\n<td>Art\u0131k bir ya\u015fam bilimleri liderinin hisselerine sahipsiniz<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Fiyat uyar\u0131lar\u0131 ayarlay\u0131n<\/td>\n<td>\u00d6nemli destek\/diren\u00e7 seviyelerini izleyin<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>\u00c7\u0131k\u0131\u015f stratejisi planlay\u0131n<\/td>\n<td>K\u00e2r alma ve zarar durdurma seviyelerini belirleyin<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>\u0130\u015flemi belgeleyin<\/td>\n<td>Vergi ama\u00e7lar\u0131 i\u00e7in kay\u0131t tutun<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Modern Ticaret Platformlar\u0131 Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Neden Cazip?<\/h2>\n<p>G\u00fcn\u00fcm\u00fcz ticaret platformlar\u0131, \u00f6zellikle yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in piyasa eri\u015fimini devrim niteli\u011finde de\u011fi\u015ftirdi. Baz\u0131 platformlar sadece 5 $ gibi d\u00fc\u015f\u00fck bir sermaye ile ba\u015flamaya izin vererek yat\u0131r\u0131m yapmay\u0131 daha \u00f6nce hayal edilemeyen \u015fekillerde demokratikle\u015ftiriyor.<\/p>\n<p>Do\u011frulama s\u00fcreci son derece verimli hale geldi; bir\u00e7ok platform tek bir belge ile KYC (M\u00fc\u015fterini Tan\u0131) gereksinimlerini bir dakikadan k\u0131sa s\u00fcrede tamaml\u0131yor. Bu eri\u015filebilirlik, bir\u00e7ok ki\u015finin borsalara kat\u0131lmas\u0131n\u0131 engelleyen geleneksel engelleri ortadan kald\u0131r\u0131yor.<\/p>\n<p>\u00d6nde gelen platformlarda 100&#8217;den fazla para \u00e7ekme y\u00f6ntemi bulunmas\u0131, yat\u0131r\u0131mc\u0131lara sermayelerini y\u00f6netmede e\u015fi g\u00f6r\u00fclmemi\u015f esneklik sunuyor. Geleneksel banka transferlerinden modern kripto para se\u00e7eneklerine kadar finansal ekosistem, \u00e7e\u015fitli tercihlere ve ihtiya\u00e7lara uyum sa\u011flamak \u00fczere evrildi.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Bio-Rad: Hassas T\u0131bb\u0131n \u00d6nc\u00fcs\u00fc<\/h2>\n<p>Bio-Rad Laboratories, ya\u015fam bilimlerinde dev bir oyuncu olarak y\u0131lda 2,6 milyar $ gelir elde ederken d\u00fcnya \u00e7ap\u0131nda 7.500&#8217;den fazla profesyonel istihdam ediyor. \u015eirketin temel g\u00fcc\u00fc, d\u00fcnya lideri oldu\u011fu klinik kalite kontrol \u00fcr\u00fcnleri ve \u00e7\u0131\u011f\u0131r a\u00e7an t\u0131bbi ke\u015fifleri destekleyen yenilik\u00e7i ya\u015fam bilimi ara\u015ft\u0131rma ara\u00e7lar\u0131nda yat\u0131yor.<\/p>\n<p>Son Stilla Technologies sat\u0131n al\u0131m\u0131, Bio-Rad&#8217;\u0131 dijital PCR teknolojisinin \u00f6n saflar\u0131na yerle\u015ftiriyor; bu pazar, hassas t\u0131p ve ileri tan\u0131 taleplerinin artmas\u0131yla patlay\u0131c\u0131 bir b\u00fcy\u00fcme ya\u015f\u0131yor. Bu stratejik hamle, mevcut damlac\u0131k dijital PCR portf\u00f6ylerini tamamlayarak sekt\u00f6rdeki en kapsaml\u0131 tekliflerden birini yarat\u0131yor.<\/p>\n<p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: 2025 y\u0131l\u0131nda Bio-Rad&#8217;\u0131n Ar-Ge ekibi, ara\u015ft\u0131rma laboratuvar\u0131 ihtiya\u00e7lar\u0131n\u0131 %94 do\u011frulukla tahmin eden yapay zeka destekli bir envanter y\u00f6netim sistemi geli\u015ftirdi\u2014bilim insanlar\u0131n\u0131n say\u0131s\u0131z saat kazanmas\u0131n\u0131 sa\u011flad\u0131 ve d\u00fcnya \u00e7ap\u0131nda t\u0131bbi at\u0131l\u0131mlar\u0131 h\u0131zland\u0131rd\u0131.<\/p>\n"},"faq":[{"question":"Bio-Rad Laboratories hisseleri nereden al\u0131n\u0131r?","answer":"Bio-Rad hisseleri NYSE'de i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden BIO sembol\u00fc ile al\u0131m yapabilirsiniz."},{"question":"Bio-Rad hisseleri i\u00e7in minimum yat\u0131r\u0131m tutar\u0131 nedir?","answer":"Minimum yat\u0131r\u0131m tutar\u0131 se\u00e7ti\u011finiz platforma ba\u011fl\u0131d\u0131r ancak genellikle 500 $ ve \u00fczeri yat\u0131r\u0131mlar \u00f6nerilir."},{"question":"Bio-Rad hisselerinin 2025 sonu fiyat tahmini nedir?","answer":"2025 y\u0131l sonu i\u00e7in Bio-Rad hisselerinin 320-340 $ aral\u0131\u011f\u0131nda olmas\u0131 beklenmektedir."},{"question":"Bio-Rad'\u0131n Stilla Technologies sat\u0131n al\u0131m\u0131 ne anlama geliyor?","answer":"Bu sat\u0131n alma, Bio-Rad'\u0131n dijital PCR teknolojisindeki yeteneklerini geni\u015fleterek pazar liderli\u011fini g\u00fc\u00e7lendirmesini sa\u011flad\u0131."},{"question":"Yeni ba\u015flayanlar Bio-Rad hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck ba\u015flayarak, d\u00fczenli yat\u0131r\u0131m yaparak ve kazan\u00e7 raporlar\u0131n\u0131 takip ederek uzun vadeli bir strateji izlemeleri \u00f6nerilir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Bio-Rad Laboratories hisseleri nereden al\u0131n\u0131r?","answer":"Bio-Rad hisseleri NYSE'de i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden BIO sembol\u00fc ile al\u0131m yapabilirsiniz."},{"question":"Bio-Rad hisseleri i\u00e7in minimum yat\u0131r\u0131m tutar\u0131 nedir?","answer":"Minimum yat\u0131r\u0131m tutar\u0131 se\u00e7ti\u011finiz platforma ba\u011fl\u0131d\u0131r ancak genellikle 500 $ ve \u00fczeri yat\u0131r\u0131mlar \u00f6nerilir."},{"question":"Bio-Rad hisselerinin 2025 sonu fiyat tahmini nedir?","answer":"2025 y\u0131l sonu i\u00e7in Bio-Rad hisselerinin 320-340 $ aral\u0131\u011f\u0131nda olmas\u0131 beklenmektedir."},{"question":"Bio-Rad'\u0131n Stilla Technologies sat\u0131n al\u0131m\u0131 ne anlama geliyor?","answer":"Bu sat\u0131n alma, Bio-Rad'\u0131n dijital PCR teknolojisindeki yeteneklerini geni\u015fleterek pazar liderli\u011fini g\u00fc\u00e7lendirmesini sa\u011flad\u0131."},{"question":"Yeni ba\u015flayanlar Bio-Rad hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck ba\u015flayarak, d\u00fczenli yat\u0131r\u0131m yaparak ve kazan\u00e7 raporlar\u0131n\u0131 takip ederek uzun vadeli bir strateji izlemeleri \u00f6nerilir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Bio-Rad Laboratories, Inc. (BIO.B) Hisseleri Nas\u0131l Al\u0131n\u0131r - Bio-Rad Laboratories, Inc. (BIO.B) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bio-Rad Laboratories, Inc. (BIO.B) Hisseleri Nas\u0131l Al\u0131n\u0131r - Bio-Rad Laboratories, Inc. (BIO.B) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-01T19:55:54+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Bio-Rad Laboratories, Inc. (BIO.B) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Bio-Rad Laboratories, Inc. (BIO.B) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-09-01T19:55:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/\"},\"wordCount\":23,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/\",\"name\":\"Bio-Rad Laboratories, Inc. (BIO.B) Hisseleri Nas\u0131l Al\u0131n\u0131r - Bio-Rad Laboratories, Inc. (BIO.B) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"datePublished\":\"2025-09-01T19:55:54+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bio-Rad Laboratories, Inc. (BIO.B) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Bio-Rad Laboratories, Inc. (BIO.B) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Bio-Rad Laboratories, Inc. (BIO.B) Hisseleri Nas\u0131l Al\u0131n\u0131r - Bio-Rad Laboratories, Inc. (BIO.B) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/","og_locale":"tr_TR","og_type":"article","og_title":"Bio-Rad Laboratories, Inc. (BIO.B) Hisseleri Nas\u0131l Al\u0131n\u0131r - Bio-Rad Laboratories, Inc. (BIO.B) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/","og_site_name":"Pocket Option blog","article_published_time":"2025-09-01T19:55:54+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Bio-Rad Laboratories, Inc. (BIO.B) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Bio-Rad Laboratories, Inc. (BIO.B) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-09-01T19:55:54+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/"},"wordCount":23,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/","name":"Bio-Rad Laboratories, Inc. (BIO.B) Hisseleri Nas\u0131l Al\u0131n\u0131r - Bio-Rad Laboratories, Inc. (BIO.B) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","datePublished":"2025-09-01T19:55:54+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Bio-Rad Laboratories, Inc. (BIO.B) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Bio-Rad Laboratories, Inc. (BIO.B) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":369536,"slug":"how-to-buy-bio-rad-laboratories","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Bio-Rad Laboratories, Inc. (BIO.B) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Bio-Rad Laboratories, Inc. (BIO.B)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/"},"pt_AA":{"locale":"pt_AA","id":369531,"slug":"how-to-buy-bio-rad-laboratories","post_title":"Como comprar a\u00e7\u00f5es da Bio-Rad Laboratories, Inc. (BIO.B) - Investimento em a\u00e7\u00f5es da Bio-Rad Laboratories, Inc. (BIO.B)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-bio-rad-laboratories\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/369535","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=369535"}],"version-history":[{"count":1,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/369535\/revisions"}],"predecessor-version":[{"id":369540,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/369535\/revisions\/369540"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334018"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=369535"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=369535"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=369535"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}